Compare MCFT & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MCFT | ASMB |
|---|---|---|
| Founded | 1968 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 477.1M | 512.1M |
| IPO Year | 2015 | 2010 |
| Metric | MCFT | ASMB |
|---|---|---|
| Price | $20.00 | $20.23 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $25.00 | ★ $52.00 |
| AVG Volume (30 Days) | 138.5K | ★ 194.6K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 91.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $348,903,000.00 | N/A |
| Revenue This Year | $77.29 | N/A |
| Revenue Next Year | $2.86 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 22.77 | N/A |
| 52 Week Low | $17.19 | $19.30 |
| 52 Week High | $28.44 | $39.71 |
| Indicator | MCFT | ASMB |
|---|---|---|
| Relative Strength Index (RSI) | 51.33 | 34.97 |
| Support Level | $19.01 | N/A |
| Resistance Level | $20.58 | $30.36 |
| Average True Range (ATR) | 0.59 | 1.07 |
| MACD | 0.18 | 0.15 |
| Stochastic Oscillator | 87.34 | 22.74 |
MasterCraft Boat Holdings Inc is a designer, manufacturer, and marketer of recreational powerboats sold through five brands: MasterCraft, Crest, Balise, Chaparral, and Robalo. It manufactures and sells recreational inboard, outboard, and sterndrive boats that it believes delivers superior performance for water skiing, wakeboarding, wakesurfing, and fishing, as well as general recreational boating. In addition, it offers various accessories, including trailers and aftermarket parts. Its segments are the Performance and Wake segment, consisting of the MasterCraft brand, which produces boats at its Vonore, Tennessee facility; The Leisure segment, consisting of Crest and Balise brands, which produces pontoon boats at its Owosso, Michigan facility; and the Recreation and Sport Fishing segment.
Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.